跳到正文
原文
Nature 健康护理主题·· 21 天前AI 评分47

贝宁低流行区麻风调查:仅30.4%居民认识早期感觉异常斑块,患者确诊时二级残疾占33.7%

Recognising the first visible signs of leprosy and late case detection in a low endemic area of Benin

AI 导读

贝宁Plateau与Zou两省的一项横断面研究纳入175例多菌型麻风患者和746名居民,患者中33.7%在确诊时已出现二级残疾(G2D),居民中仅30.4%能说出麻风最早可识别的表现,即持续存在并伴感觉减退或异常的斑块。

正文

Abstract

Although Benin reports fewer than 100 new leprosy cases per year, 47–54% of those notified between 2022 and 2025 had grade 2 disability (G2D) at diagnosis. We examined whether affected individuals and their neighbours recognised the disease by its first recognisable sign, a persistent skin patch with loss or alteration of sensation, or by its perceived late consequences. An analytical cross-sectional study was conducted in the Plateau and Zou departments of Benin among 175 people with multibacillary leprosy (64.1% of 273 multibacillary cases registered there in 2013–2023; 89 paucibacillary cases registered over the same period, 24.6% of the 362 registered cases, were not eligible) and 746 residents randomly selected within 100 m of the patients’ homes. Because the diagnosis was never disclosed, residents were analysed as members of endemic rural communities rather than as traced contacts, with no claim of representativeness. Recognition of this sign was compared with the perception of late consequences, and associations with G2D were examined using logistic regression. Among residents, 66.9% had heard of leprosy. Among those aware, 62.5% cited death, whereas the patch with altered sensation (45.5%) and disability or impairment (47.5%) were cited at indistinguishable rates; across all residents, only 30.4% could name this early sign. G2D was recorded in 33.7% of affected individuals: 19.4% of those presenting with a patch, 50.0% with sensory loss and 80.0% with visible disability. Compared with presentation for a patch, presentation for sensory loss was associated with higher odds of G2D (adjusted odds ratio (aOR) 3.85, 95% confidence interval (CI) 1.64–9.05). No difference was observed between actively and passively detected cases (36.1% versus 33.1%; OR 1.14, 95% CI 0.53–2.46), a comparison limited by only 36 active cases. In principle, 96.4% of residents would accept preventive medication; however, acceptance fell to 73.9% once distance, time and side effects were taken into account. In these low-endemic rural communities, leprosy was more evident through its perceived late consequences than its initial manifestations, and disability at diagnosis tracked the stage at which patients entered care. The findings support communication centred on persistent patches with altered sensation, reinforced recognition skills among first-line workers, and integration of education with case finding and contact-based prevention. The observational design precludes causal inference.

Abbreviations

aOR:

Adjusted odds ratio

AUC:

Area under the receiver operating characteristic curve

CI:

Confidence interval

G2D:

Grade 2 disability

MB:

Multibacillary

ODK:

Open data kit

OR:

Odds ratio

PB:

Paucibacillary

PEP:

Post-exposure prophylaxis

PNLLUB:

Programme National de Lutte contre la Lèpre et l’Ulcère de Buruli (National Leprosy and Buruli Ulcer Control Programme)

SDDR-PEP:

Single double-dose rifampicin post-exposure prophylaxis

STROBE:

Strengthening the reporting of observational studies in epidemiology

WHO:

World Health Organization

Acknowledgements

We thank all the members of the 2PEP4LEP project team and the Programme National de Lutte contre la Lèpre et l’Ulcère de Buruli in Benin for their administrative and technical support, and the Raoul Follereau and ANESVAD Foundations.

Funding

The data used in this article are drawn from the research project “Étude de la faisabilité et de l’efficacité du dépistage et de la prise en charge intégrés des MTN-MC, associés à l’administration d’une double dose unique de rifampicine à titre de prophylaxie post-exposition chez des personnes exposées à la lèpre au Bénin et en Côte d’Ivoire (2PEP4LEP)”, funded by the ANESVAD Foundation and the Raoul Follereau Foundation under grant REG-3723/21. Representatives of both funders are co-authors and contributed to the design of the study and to the review of the manuscript; the funders had no role in data collection, in the statistical analysis or in the decision to submit for publication.

Author information

Author notes

  1. Fifamin Noël Christelle Gbaguidi and Sètondji Diane Zanvo have contributed equally to this work.

Authors and Affiliations

  1. Centre Interfacultaire de Formation et de Recherche en Environnement pour le Développement Durable (CIFRED), Université d’Abomey-Calavi, Abomey-Calavi, Bénin

    Fifamin Noël Christelle Gbaguidi, Sètondji Diane Zanvo, Sèdjro Gimatal Esaï Anagonou, Yévèdo Borel Tossou, Karine Lucrèce Marie Codjo-Seignon, Sonagnon Inès Elvire Agbo, Jean Gabin Houezo & Roch Christian Johnson

  2. Ingénierie et Mathématiques, Université Nationale des Sciences, Technologies, Abomey, Bénin

    Fifamin Noël Christelle Gbaguidi, Sètondji Diane Zanvo & Armelle Sabine Yélignan Hounkpatin

  3. Institut Régional de Santé Publique de Ouidah, Université d’Abomey- Calavi, Abomey-Calavi, Bénin

    Karine Lucrèce Marie Codjo-Seignon & Vignon Bédié

  4. Fondation Anesvad, Bilbao, Spain

    Cristina Juan Jimenez & Anna Gine-March

  5. Fondation Raoul Follereau, Paris, France

    Alice Toussaint, Pierre Velut & Roch Christian Johnson

  6. German Leprosy and Tuberculosis Relief Association (DAHW), Würzburg, Germany

    Anil Fastenau

Authors

  1. Fifamin Noël Christelle Gbaguidi
  2. Sètondji Diane Zanvo
  3. Sèdjro Gimatal Esaï Anagonou
  4. Yévèdo Borel Tossou
  5. Karine Lucrèce Marie Codjo-Seignon
  6. Sonagnon Inès Elvire Agbo
  7. Jean Gabin Houezo
  8. Vignon Bédié
  9. Cristina Juan Jimenez
  10. Alice Toussaint
  11. Pierre Velut
  12. Anil Fastenau
  13. Anna Gine-March
  14. Armelle Sabine Yélignan Hounkpatin
  15. Roch Christian Johnson

Corresponding author

Correspondence to Karine Lucrèce Marie Codjo-Seignon.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study protocol was approved by the National Ethics Committee for Health Research (Comité National d’Éthique pour la Recherche en Santé) of the Ministry of Health of Benin under reference CNERS 011/2024, session of 27 August 2024; the favourable opinion was signed and became effective on 15 October 2024, before any activity involving participants, and was valid for one year. Data collection that continued beyond that year was covered by the committee’s re-approval of the protocol under reference CNERS 004/2026, session of 18 April 2026, which took effect on 16 October 2025. The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants; the parent or guardian consented for minors, who also gave their own assent, and illiterate participants provided a fingerprint in the presence of an independent witness.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gbaguidi, F.N.C., Zanvo, S.D., Anagonou, S.G.E. et al. Recognising the first visible signs of leprosy and late case detection in a low endemic area of Benin. Sci Rep (2026). https://doi.org/10.1038/s41598-026-77631-1

Download citation

  • Received: 16 August 2026

  • Accepted: 21 October 2026

  • Published: 30 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-77631-1

Keywords

来源:Nature 健康护理主题 · nature.com